A two pulse drug delivery system for amoxicillin: An attempt to counter the scourge of bacterial resistance against antibiotics

K. Traynor, D. W. Newton, J. M. Hrushesky and R. J. Reiter, A pharmacist primer on chronotherapeutics, Am. Phar. 32 (1992) 261-269.Search in Google Scholar

J. Ali, N. Saigal, M. J. Qureshi, S. Baboota and A. Ahuja, Chronopharmaceutics: A promising drug delivery finding of the last two decades, Rec. Pat. Drug Deliv. Formul. 4 (2010) 129-144; DOI: 10.2174/187221110791184962.10.2174/187221110791184962Search in Google Scholar

J. Ali, S. Baboota, A. Ahuja and N. Saigal, Distinctive features of »chronotherapeutic« and »pulsatile « drug delivery systems negating the practice of their interchangeable terminology, J. Drug Target. 18 (2010) 413-419; DOI: 10.3109/10611861003587250.10.3109/10611861003587250Search in Google Scholar

N. Saigal, S. Baboota, A. Ahuja and J. Ali, Site specific chronotherapeutic drug delivery systems: A patent review, Rec. Pat. Drug Deliv. Formul. 3 (2009) 64-70; DOI: 10.2174/187221109787158328.10.2174/187221109787158328Search in Google Scholar

N. Saigal, S. Baboota, A. Ahuja and J. Ali, Multiple-pulse drug delivery system: setting a new paradigm for infectious disease therapy, Expert Opin. Drug Deliv. 6 (2009) 441-452; DOI: 10.1517/17425240902895972.10.1517/17425240902895972Search in Google Scholar

A. C. Ross, R. J. MacRae, M. Walther and H. N. Stevens, Chronopharmaceutical drug delivery from a pulsatile capsule device based on programmable erosion, J. Pharm. Pharmacol. 52 (2000) 903-909.10.1211/0022357001774787Search in Google Scholar

S. Arora, J. Ali, A. Ahuja, S. Baboota and J. Qureshi, Pulsatile drug delivery system: An approach for controlled drug delivery, Indian J. Pharm. Sci. 86 (2006) 295-300; DOI: 10.4103/0250-474X.26655.10.4103/0250-474X.26655Search in Google Scholar

T. Bussemer, I. Otto and R. Bodmeier, Pulsatile drug-delivery systems, Crit. Rev. Ther. Drug Carrier Syst. 18 (2001) 433-458; DOI: 10.1517/17425240903490401.10.1517/17425240903490401Search in Google Scholar

W. A. Craig, Antibiotic selection factors and description of a hospital-based outpatient antibiotic therapy program in the USA, Eur. J. Clin. Microbiol. Infect. Dis. 14 (1995) 636-642; DOI: 10.1007/BF01690745.10.1007/BF01690745Search in Google Scholar

W. A. Craig, Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men, Clin. Infect. Dis. 26 (1998) 1-12; DOI: 10.1086/516284.10.1086/516284Search in Google Scholar

B. Vogelman and W. A. Craig, Kinetics of antimicrobial activity, J. Pediatr. 108 (1986) 835-840; DOI: 10.1016/S0022-3476(86)80754-5.10.1016/S0022-3476(86)80754-5Search in Google Scholar

S. Holm, I. Odenholt and O. Cars, Paradoxical effects of antibiotics, Scand. J. Infect. Dis. 74 (1991) 113-117.Search in Google Scholar

United States Pharmacopoeia XXIV, National Formulary XIX, USP Convention, Rockwille (MD) 2000.Search in Google Scholar

S. Klein, J. Stein and J. Dressman, Site specifie delivery of anti-inflammatory drugs in the gastrointestinal tract: an in vitro release model, J. Pharm. Pharmacol. 57 (2005) 709-719; DOI: 10.1211/0022357056172.10.1211/002235705617215969925Search in Google Scholar